Document is current
Any future updates will be listed below
-
Authors
Mougiakakos, Dimitrios https://orcid.org/0000-0002-2817-6660
- License Information
-
More Information
Article History
Received: 24 August 2024
Revised: 25 September 2024
Accepted: 29 September 2024
First Online: 8 October 2024
Competing interests
: DM has received speaker honoraria and consulting fees from Abbvie, Astra Zeneca, BMS, Beigene, Galapagos, Gilead, Janssen, Kyverna, Miltenyi, and Novartis.
